OPR - Delayed Quote • USD IRMD Jul 2024 60.000 call (IRMD240719C00060000) Follow 2.0000 0.0000 (0.00%) At close: December 15 at 9:32 AM EST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for IRMD240719C00060000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: IRMD IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd IRADIMED CORPORATION's (NASDAQ:IRMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference Those who invested in IRADIMED (NASDAQ:IRMD) three years ago are up 93% Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD) Should You Invest in IRadimed Corporation (IRMD)? Institutional investors own a significant stake of 39% in IRadimed Corporation (NASDAQ:IRMD) IRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Call Transcript iRadimed Corp (IRMD) Reports Record Revenues and Robust Earnings Growth in Q4 and Full-Year 2023 IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th. IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
